Toxicity in the era of immune checkpoint inhibitor therapy

Overview of attention for article published in Frontiers in immunology, August 2024

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (60th percentile)
Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

twitter: 3 X users

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 16,339 followers.

RT @JlMorell: Revisión 📄de efectos adversos inmunomediados de inhibidores de checkpoints 🛂 🔓 https://t.co/OxagqTK4iO https://t.co/hknPOZFE…

09 Sep 2024

Reply Repost Favourite

Revisión 📄de efectos adversos inmunomediados de inhibidores de checkpoints 🛂 🔓 https://t.co/OxagqTK4iO https://t.co/hknPOZFEAC

09 Sep 2024

Reply Repost Favourite

Happy to share my latest review paper: "Toxicity in the era of immune checkpoint inhibitor (ICI) therapy: https://t.co/9n6qGh5fr1. I'm currently working on two types of ICI-induced toxicity models (colitis, and arthritis). I also work with recurrent ICI-ar

26 Aug 2024

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.